A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 2)

Condition:   COVID-19 Intervention:   Biological: COVIVAC vaccine Sponsors:   Institute of Vaccines and Medical Biologicals, Vietnam;   National Institute of Hygiene and Epidemiology (NIHE), Vietnam;   Center for Disease Control of Thai Binh Province, Vietnam Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials